Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Net Cash Flow (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Net Cash Flow for 8 consecutive years, with -$33.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 74.55% to -$33.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$33.2 million, a 36.44% decrease, with the full-year FY2025 number at -$33.2 million, down 36.44% from a year prior.
  • Net Cash Flow was -$33.5 million for Q4 2025 at Select Medical Holdings, down from $7.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $173.2 million in Q1 2021 to a low of -$673.7 million in Q4 2021.
  • A 5-year average of -$27.5 million and a median of $2.9 million in 2023 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 438.47% in 2024; the steepest drop was 2106.91% in 2024.
  • Select Medical Holdings' Net Cash Flow stood at -$673.7 million in 2021, then skyrocketed by 98.47% to -$10.3 million in 2022, then skyrocketed by 163.64% to $6.6 million in 2023, then plummeted by 2106.91% to -$131.8 million in 2024, then skyrocketed by 74.55% to -$33.5 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Net Cash Flow are -$33.5 million (Q4 2025), $7.7 million (Q3 2025), and -$864000.0 (Q2 2025).